Eterna Therapeutics Files 8-K for Bylaws and Financials

Ticker: ERNAW · Form: 8-K · Filed: Mar 26, 2025 · CIK: 748592

Eterna Therapeutics Inc. 8-K Filing Summary
FieldDetail
CompanyEterna Therapeutics Inc. (ERNAW)
Form Type8-K
Filed DateMar 26, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, financial-reporting

TL;DR

Eterna Therapeutics filed an 8-K on 3/26/25 for bylaws & financials.

AI Summary

Eterna Therapeutics Inc. filed an 8-K on March 26, 2025, reporting amendments to its articles of incorporation or bylaws and financial statements. The company, formerly known as Brooklyn ImmunoTherapeutics, Inc., is incorporated in Delaware and operates in the Pharmaceutical Preparations sector.

Why It Matters

This filing provides updates on Eterna Therapeutics' corporate governance and financial reporting, which are crucial for investors to assess the company's operational status and compliance.

Risk Assessment

Risk Level: low — This is a routine filing for corporate updates and financial statements, not indicating any immediate operational or financial distress.

Key Players & Entities

  • Eterna Therapeutics Inc. (company) — Registrant
  • Brooklyn ImmunoTherapeutics, Inc. (company) — Former Name
  • March 26, 2025 (date) — Date of Report
  • Delaware (jurisdiction) — State of Incorporation

FAQ

What specific amendments were made to Eterna Therapeutics' articles of incorporation or bylaws?

The filing indicates amendments were made, but the specific details of these amendments are not provided in the summary text.

When was Eterna Therapeutics Inc. formerly known as Brooklyn ImmunoTherapeutics, Inc.?

The date of the name change from Brooklyn ImmunoTherapeutics, Inc. to Eterna Therapeutics Inc. was March 25, 2021.

What is Eterna Therapeutics Inc.'s Standard Industrial Classification (SIC) code?

Eterna Therapeutics Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.

Where is Eterna Therapeutics Inc. incorporated?

Eterna Therapeutics Inc. is incorporated in Delaware.

What is the business address of Eterna Therapeutics Inc.?

The business address is 1035 Cambridge Street, Suite 18A, Cambridge, MA 02141.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 26, 2025 regarding Eterna Therapeutics Inc. (ERNAW).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.